Addison’s disease treatment market is growing with advancements in hormone replacement therapies, including glucocorticoids and mineralocorticoids, ensuring better disease management by 2035.

Cena Hermus, 7, was two years old when she was diagnosed with a rare, life-threatening disorder that causes severe obesity.